Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Europe Gastrointestinal Drugs Market

ID: MRFR/Pharma/0165-HCR
85 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Europe, Middle East and Africa Gastrointestinal Drugs Market Research Report, by Drug Category (Acid Neutralizers, Laxatives and Antidiarrheal, Anti-inflammatory drugs), By Route of Administration (Oral, Parenteral, Rectal), By Disease Type (Gastroesophageal Reflux Disease, Inflammatory Bowel Disease), by end user (Hospital Pharmacies, Retail Pharmacies) - Forecast till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 INTRODUCTION
    1. 1.1 DEFINITION
    2. 1.2 SCOPE OF STUDY
      1. 1.2.1 RESEARCH OBJECTIVE
      2. 1.2.2 ASSUMPTIONS & LIMITATIONS
        1. 1.2.2.1 ASSUMPTIONS
        2. 1.2.2.2 LIMITATIONS
    3. 1.3 MARKET STRUCTURE:
  2. 2 RESEARCH METHODOLOGY
    1. 2.1 RESEARCH PROCESS:
    2. 2.2 PRIMARY RESEARCH
    3. 2.3 SECONDARY RESEARCH:
  3. 3 MARKET DYNAMICS
    1. 3.1 DRIVERS
    2. 3.2 RESTRAINTS
    3. 3.3 OPPORTUNITIES
    4. 3.4 MACROECONOMIC INDICATORS
  4. 4 MARKET FACTOR ANALYSIS
    1. 4.1 PORTERS FIVE FORCES MODEL
    2. 4.2 BARGAINING POWER OF SUPPLIERS
    3. 4.3 BARGAINING POWER OF BUYERS
    4. 4.4 THREAT OF NEW ENTRANTS
    5. 4.5 THREAT OF SUBSTITUTES
    6. 4.6 INTENSITY OF RIVALRY
  5. 5 EUROPE, Europe Gastrointestinal Drugs Market, BY DRUG CATEGORY
    1. 5.1 ACID NEUTRALIZERS
      1. 5.1.1 ANTACIDS
      2. 5.1.2 H2 ANTAGONISTS
      3. 5.1.3 PROTON PUMP INHIBITORS
      4. 5.1.4 OTHERS
    2. 5.2 LAXATIVES AND ANTIDIARRHEAL
    3. 5.3 ANTIEMETIC
    4. 5.4 ANTI-INFLAMMATORY DRUGS
    5. 5.5 OTHER
  6. 6 EUROPE, Europe Gastrointestinal Drugs Market, BY ROUTE OF ADMINISTRATION
    1. 6.1 ORAL
    2. 6.2 PARENTERAL
    3. 6.3 RECTAL
  7. 7 EUROPE, MIDDLE EAST AND AFRICA GASTROINTESTINAL DRUGS MARKET, DISEASE TYPE
    1. 7.1 GASTROESOPHAGEAL REFLUX DISEASE
    2. 7.2 INFLAMMATORY BOWEL DISEASE
    3. 7.3 OTHER
  8. 8 EUROPE, MIDDLE EAST AND AFRICA GASTROINTESTINAL DRUGS MARKET
    1. 8.1 HOSPITAL PHARMACIES
    2. 8.2 RETAIL PHARMACIES
    3. 8.3 OTHER
  9. 9 EUROPE, Europe Gastrointestinal Drugs Market, BY REGION
    1. 9.1 INTRODUCTION
    2. 9.2 EUROPE
      1. 9.2.1 WESTERN EUROPE
        1. 9.2.1.1 GERMANY
        2. 9.2.1.2 FRANCE
        3. 9.2.1.3 ITALY
        4. 9.2.1.3 SPAIN
        5. 9.2.1.5 UK
        6. 9.2.1.6 REST OF WESTERN EUROPE
      2. 9.2.2 EASTERN EUROPE
    3. 9.3 MIDDLE EAST & AFRICA
  10. 10 COMPETITIVE LANDSCAPE
    1. 10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
      1. 10.1.1 STRATEGIC PARTNERSHIP
      2. 10.1.2 MERGER & ACQUISITION
  11. 11 COMPANY PROFILE
    1. 11.1 ABBVIE INC.
      1. 11.1.1 OVERVIEW
      2. 11.1.2 PRODUCT OVERVIEW
      3. 11.1.3 FINANCIALS
      4. 11.1.4 KEY DEVELOPMENTS
    2. 11.2 ASTRAZENECA
      1. 11.2.1 OVERVIEW
      2. 11.2.2 PRODUCT OVERVIEW
      3. 11.2.3 FINANCIALS
      4. 11.2.4 KEY DEVELOPMENTS
    3. 11.3 JOHNSON & JOHNSON
      1. 11.3.1 OVERVIEW
      2. 11.3.2 PRODUCT OVERVIEW
      3. 11.3.3 FINANCIALS
      4. 11.3.4 STRATEGY
      5. 11.3.5 KEY DEVELOPMENT
    4. 11.4 TAKEDA PHARMACEUTICAL COMPANY LIMITED
      1. 11.4.1 OVERVIEW
      2. 11.4.2 PRODUCT OVERVIEW
      3. 11.4.3 FINANCIALS
      4. 11.4.4 KEY DEVELOPMENTS
    5. 11.5 ALLERGAN PLC
      1. 11.5.1 OVERVIEW
      2. 11.5.2 PRODUCT OVERVIEW
      3. 11.5.3 FINANCIALS
      4. 11.5.4 KEY DEVELOPMENTS
    6. 11.6 OTHERS

Europe, Middle East and Africa Gastrointestinal Drugs Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment